Immunogenicity of an inactivated Rift Valley fever vaccine in humans: A 12-year experience

Vaccine

Volumn 18, Issue 1-2, 1999, Pages 181-189

  Pittman, Phillip R ^a   Liu, C T ^a   Cannon, Timothy L ^a   Makuch, Richard S ^a   Mangiafico, Joseph A ^a   Gibbs, Paul H ^a   Peters, Clarence J ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Clinical trials; Long term immunity; Rift Valley fever virus; RVF vaccine

Indexed keywords

VIRUS VACCINE;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMORRHAGIC FEVER; HUMAN; IMMUNOGENICITY; INFECTION RISK; MALE; NORMAL HUMAN; OCCUPATIONAL HAZARD; OCCUPATIONAL SAFETY; PRIORITY JOURNAL; RIFT VALLEY FEVER BUNYAVIRUS; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; FEMALE; HALF-LIFE; HUMANS; IMMUNIZATION; MALE; MIDDLE AGED; PROBABILITY; RIFT VALLEY FEVER VIRUS; TIME FACTORS; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 0033588528     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00218-2     Document Type: Article

References (46)

1. Swanepoel R., Coetzer J.A.W. Rift Valley fever. Coetzer J.A.W., Thomson G.R., Tustin R.C. Infectious diseases of livestock with special reference to southern Africa. 1994;688 Oxford University Press, Cape Town.
2. Peters CJ, Linthicum KJ. Rift Valley fever. In: Baran GW, editor. Viral Zoonoses, 2nd ed. Handbook series of Zoonoses, Section B. Boca Raton, FL: CRC Press, 1994. p. 125.
3. Peters C.J., Liu C.T., Anderson G.W. Jr, Morrill J.C., Jahrling P.B. Pathogenesis of viral hemorrhagic fever: Rift Valley fever and Lassa fever contrasted. Rev. Infect. Dis. 2:1989;S743-S749.
4. Meegan JM, Bailey CL. Rift Valley fever. In: Monath TP, editor. The arboviruses: epidemiology and ecology, Vol. 4. Boca Raton, FL: CRC Press, 1988. p. 51.
5. Morvan J., Rollin P.E., Laventure S., Rakotoarivony I., Roux J. Rift Valley fever epizootic in the central highlands of Madagascar. Res. Virol. 143:1992;407-415.
6. Peters C.J. Emergency of Rift Valley fever. Saluzzo J.F., Dodet B. Factors in the emergence of arbovirus diseases. 1997;253 Elsevier Science, Paris.
7. Arthur R.R., El-Sharkawy M.S., Cope S.E., Botros B.A., Oun S., Morrill J.C., Shope R.E., Hibbs R.G., Darwish M.A., Imam I.Z. Recurrence of Rift Valley fever in Egypt. Lancet. 342:1993;1149-1150.
8. Meegan J.M. The Rift Valley fever epizootic in Egypt 1977-1978. I. Description of the epizootic and virological studies. Trans. R. Soc. Trop. Med. Hyg. 73:1979;618-623.
9. Rift Valley fever - East Africa, 1997-1998. MMWR. 47:1998;261-264.
10. Linthicum K.J., Davies F.G., Kairo A., Bailey C.L. Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya, J. Hyg. Cambrige. 95:1985;197-209.
11. Rift Valley fever - East Africa, 1997-1998. Am. J. Trop. Med. Hyg. 47:1998;261-264.
12. Turell M.J., Perkins P.V. Transmission of Rift Valley fever virus by the sand fly, Phlebotomus duboscqi (Diptera: Psychodidae). Am. J. Trop. Med. Hyg. 42:1990;185-188.
13. Daubney R., Hudson J.R., Garnham P.C. Enzootic hepatitis or Rift Valley fever: an undescribed virus disease of sheep, cattle and man from East Africa. J. Pathol. Bacteriol. 34:1931;545-579.
14. Linthicum K.J., Bailey C.L., Davies F.G., Tucker C.J. Detection of Rift Valley fever viral activity in Kenya by satellite remote sensing imagery. Science. 235:1987;1656-1659.
15. Shope R.E., Peters C.J., Davies F.G. The spread of Rift Valley fever and approaches to its control. Bull. WHO. 60:1982;299-304.
16. Gear J.H.S. Clinical aspects of African viral hemorrhagic fevers. Rev. Infect. Dis. 4:(Suppl. 2):1989;S777-S782.
17. McIntosh B.M., Russell D., Dos Santos I., Gear J.H. Rift Valley fever in humans in South Africa. South African Med. J. 58:1980;803-806.
18. Adam F., Jouan A., Riou O., Philippe B., Coulibaly I., Berlioz B., Meegan J., Leguenno B., Digoutte J.P. Development of a biological and clinical prognostic model of Rift Valley fever. Bull. Soc. Pathol. Exo. Filiales. 82:1989;628-636.
19. Peters C.J., Jones D., Trotter R., Donaldson J., White J., Stephen E., Slone T.W. Jr., T W. Experimental Rift Valley fever in Rhesus macaques. Arch. Virol. 99:1988;31-44.
20. Anderson G.W. Jr., Slone T.W. Jr., Peters C.J. Pathogenesis of Rift Valley fever virus (RVFV) in inbred rats. Microbiol. Pathogen. 2:1987;283-293.
21. Cosgriff T.M., Morril J.C., Jennings G.B., Hodgson L.A., Slayter M.V., Gibbs P.H., Peters C.J. Hemostatic derangement produced by Rift Valley fever virus in rhesus monkeys. Rev. Infect. Dis. 2:(Suppl. 4):1989;S807-S814.
22. Randall R., Gibbs C.J. Jr., Aulisio C.G., Binn L.N., Harrison V.R. The development of a formalin-killed Rift Valley fever virus vaccine for use in man. J. Immunol. 89:1962;660-671.
23. Randall R., Binn L.N., Harrison V.R. Immunization against Rift Valley fever virus, studies on the immunogenicity of lyophilized formalin-inactivated vaccine. J. Immunol. 93:1964;293-299.
24. Eddy GA, Peters CJ, Meadors G, Cole Jr. FE. Rift Valley fever vaccine for humans. In: Swartz TA, Klingberg MA, Goldblum N, editors. Contributions to epidemiology and biostatistics. Rift Valley fever, Vol. 3. Basel: S. Karger, 1981. p. 124.
25. Niklasson B.S., Meadors G.F., Peters C.J. Active and passive immunization against Rift Valley fever virus infection in Syrian hamsters. Acta Pathol. Microbiol. Immunol. Scand. C. 92:1984;197-200.
26. Niklasson B. Rift Valley fever virus vaccine trial: study of side-effects in humans. Scand. J. Infect. Dis. 14:1982;105-109.
27. Niklasson B., Peters C.J., Bengtsson E., Norrby E. Rift Valley fever virus vaccine trial: study of neutralizing antibody response in humans. Vaccine. 3:1985;123-127.
28. Meadors G.F. III, Gibbs P.H., Peters C.J. Evaluation of a new Rift Valley fever vaccine: safety and immunogenity trials. Vaccine. 4:1986;179-184.
29. Caplen H., Peters C.J., Bishop D.H.L. Mutagen directed attenuation of Rift Valley fever as a method of vaccine development. J. Gen. Virol. 66:1985;2271-2277.
30. Turell M.J., Saluzzo J.F., Tammariello R.F., Smith J.F. Generation and transmission of Rift Valley fever viral reassortants by the mosquito Culex pipiens. J. Gen. Virol. 71:1990;2307-2312.
31. Morrill J.C., Carpenter L., Taylor D., Ramsburg H.H., Quance J., Peters C.J. Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep. Vaccine. 9:1991;35-41.
32. Baskerville A., Hubbard K.A., Stephenson J.R. Comparison of the pathogenicity for pregnant sheep Rift Valley fever virus and a live attenuated vaccine. Res. Vet. Sci. 52:1992;307-311.
33. Morrill J.C., Mebus C.A., Peters C.J. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle. Am. J. Vet. Res. 58:1997;1104-1109.
34. Biosafety in microbiological and biomedical laboratories. 3rd ed. 1993;130-132 US Department of Health and Human Services, Public Health Service.
35. Kark J.D., Aynor Y., Peters C.J. A Rift Valley fever vaccine trial. 2. Serological response to booster doses with a comparison or intradermal versus subcutaneous injection. Vaccine. 3:1985;117-122.
36. Kark J.D., Aynor Y., Peters C.J. A Rift Valley fever vaccine trial. Am. J. Epidemiol. 116:1982;808-820.
37. Pittman P.R., Makuch R.S., Mangiafico J.A., Cannon T.L., Gibbs P.H., Peters C.J. Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine. Vaccine. 14:1996;337-343.
38. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Ass. 53:1958;457-481.
39. SAS/STAT User's Guide, version 6, Vol. 2:1007-1069. SAS Inst. Cary, NC, 1990:27513.
40. Peters C.J., Reynolds J.A., Slone T.W., Jones D.E., Stephen E.L. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator. Antiviral Res. 6:1986;285-297.
41. Francis T. Jr., Magill T.P. Rift Valley fever. A report of three cases of laboratory infection and the experimental transmission of the disease to ferrets. J. Exp. Med. 62:1935;433-448.
42. Kitchen S.F. Laboratory infections with the virus of Rift Valley fever. Am. J. Trop. Med. Hyg. 14:1934;547-564.
43. Schwentker F.F., Rivers T.M. Rift Valley fever in man. Report of a fatal laboratory infection complicated by thrombophlebitis. J. Exp. Med. 59:1934;305-313.
44. Smithburn K.C., Mahaffy A.F., Haddow A.J., Kitchen S.F., Smith J.F. Rift Valley fever: accidental infections among laboratory workers. J. Immunol. 62:1949;213-227.
45. Battles J.K., Dalrymple J.M. Genetic variation among geographic isolates of Rift Valley fever virus. Am. J. Trop. Med. Hyg. 39:1988;617-631.
46. Niklasson B., Peters C.J., Grandien M., Wood O. Detection of human immunoglobulins G and M antibodies to Rift Valley fever virus by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 19:1984;225-229.